The short version of Stenabolic fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-11-30. Anything still debated is marked as such rather than presented as settled.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also marketed informally as Stenabolic |
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ |
| Molecular formula | C24H30ClN3O4S | Approximate molecular weight 492 g/mol |
| CAS Registry Number | 1379686-30-2 | Identifier for the parent compound |
| Regulatory status | Not approved for human use | Prohibited in sport by WADA |
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Sheikha Fatima bint Hazza bin Zayed Al Nahyan. Sheikha Salama bint Hazza bin Zayed Al Nahyan. Sheikh Zayed bin Hazza bin Zayed Al Nahyan (born 1995). He has one son. Sheikh Hazza bin Zayed Al Nahyan (born 2026). Sheikha Meera bint Hazza bin Zayed Al Nahyan. She married Sheikh Zayed bin Mansour bin Zayed Al Nahyan on May 5, 2022. Sheikh Mohammed bin Hazza bin Zayed Al Nahyan (born 2002).
== Varieties == Cattierite (CoS2), vaesite (NiS2) and hauerite (MnS2), as well as sperrylite (PtAs2) are similar in their structure and belong also to the pyrite group. Bravoite is a nickel-cobalt bearing variety of pyrite, with > 50% substitution of Ni2+ for Fe2+ within pyrite. Bravoite is not a formally recognised mineral, and is named after the Peruvian scientist Jose J. Bravo (1874–1928).
In particular, more distant atoms within corresponding features are exponentially downweighted to reduce the effects of noise introduced by loop mobility, helix torsions, and other minor structural variations. Because DALI relies on an all-to-all distance matrix, it can account for the possibility that structurally aligned features might appear in different orders within the two sequences being compared. The DALI method has also been used to construct a database known as FSSP (Fold classification based on Structure-Structure alignment of Proteins, or Families of Structurally Similar Proteins) in which all known protein structures are aligned with each other to determine their structural neighbors and fold classification. There is a searchable database based on DALI as well as a downloadable program and web search based on a standalone version known as DaliLite.
=== Approved drugs === Emoxypine (ethylmethylhydroxypyridine; Mexidol) – antioxidant and unknown mechanism of action [135] Tandospirone (metanopirone; Sediel; SM-3997) – serotonin 5-HT1A receptor partial agonist [136] Tianeptine (Coaxil; Stablon; Tatinol) – weak atypical μ-opioid receptor agonist and other actions [137]
Sources: en.wikipedia.org
Most fossils of cnidarians have been found in marine paleoenvironments, which is consistent with the marine habitat of most extant cnidarian species. In the Carboniferous and Permian, some cnidarian fossils have been reported in non-marine (continental environments). These have typically been interpreted as freshwater paleoenvironments, but this is uncertain given that brackish (even hypersaline) continental water bodies exist (even outside deserts) and harbor moderate biodiversity, that continental habitat is inferred when typical marine markers are absent, and negative evidence is inherently weak, all of which led to controversies about many of these supposedly freshwater deposits. Indeed, some continental Paleozoic cnidarians are thought to have inhabited salt lakes. A study even argued that fossil medusoids (some of which have been interpreted as freshwater by other studies) are "restricted lagoonal facies where anoxia and hypersalinity fostered preservation", and another one reinterpreted fossils of Essexella that had initially been interpreted as freshwater medusae from Mazon Creek as euryhaline semi-infaunal anemone. Hydroconozoa is an extinct class of cnidarians, established by K.B. Korde in 1964 based on Lower Cambrian fossils from Tuva, USSR. These conical and cylindrical organisms, including genera like Hydroconus and Tuvaeconus, possessed external skeletons with features resembling both scyphozoans and tetracorals. Their unique skeletal structures suggest a distinct lineage within early cnidarian evolution.
== Development == Half-Life: Opposing Force was announced by developer Gearbox Software on April 15, 1999. In their press release, founder Randy Pitchford stated that "our number one goal is to preserve the integrity of Half-Life and provide new experiences that expand upon the sensation of the original". The name Opposing Force has a double meaning, referring both to the fact that the player is one of the enemies in the original game, as well as to Newton's third law of motion. In a later interview, Pitchford stated that he believed that Valve offered Gearbox the chance to make a Half-Life expansion was from a wish "to focus on their future titles". In addition, Pitchford commented that Valve and Gearbox had agreed not to "severely modify" the game engine used by Half-Life and Opposing Force as it "risks breaking all of the wonderful work" that the game's custom content community was creating. Substantial information on Opposing Force's development direction, as well as new locations, characters and story were revealed at the 1999 Electronic Entertainment Expo convention. The official website for Opposing Force, hosted by publisher Sierra Studios, was put online in July 1999. Opposing Force was developed in 8 months by a team of more than 15 people. Over the course of development, Gearbox acquired various outside talent to assist in designing some aspects. In June 1999, Gearbox announced that level designer Richard Gray would be assisting in developing the multiplayer aspects.
== Organizations == SST Inc. also known as ShotSpotter Inc. Silicon Storage Technology, Inc, former US semiconductor manufacturer School of Science and Technology, high school in Oregon, US School of Science and Technology, Singapore Special Security Team, a counter-terrorist unit of the Japanese Coast Guard
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.
No. SR9009 has not been approved as a therapeutic drug in the United States, European Union, or other major markets. Human safety and efficacy data are very limited. Its presence in consumer products does not imply regulatory approval.
The World Anti-Doping Agency lists SR9009 as a prohibited substance because it can alter gene expression and metabolic pathways relevant to performance. The ban applies at all times, not only during competition. Detection relies on laboratory methods such as mass spectrometry.
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.